Furthermore, we found that other antidiabetic drugs, including sulfonylurea, DPP4 inhibitor, thiazolidinediones, and insulin, were not significantly related to NAFLD severity. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.